Logotype for A. O. Smith Corporation

A. O. Smith (AOS) Q4 2024 earnings summary

Event summary combining transcript, slides, and related documents.

Logotype for A. O. Smith Corporation

Q4 2024 earnings summary

9 Jan, 2026

Executive summary

  • 2024 sales declined 1% to $3.8B, with adjusted EPS at $3.73, both down year-over-year, mainly due to lower China sales and weaker North America water heater demand, while India sales grew 13% in local currency and the Pureit acquisition closed in Q4.

  • $496M was returned to shareholders via dividends and share repurchases; approximately 3.8M shares repurchased in 2024.

  • Boiler sales in North America rose 8%, offsetting weaker water heater demand; cost optimization and restructuring initiatives were launched in China and North America water treatment.

  • Teams focused on strategic investments, including a new tankless manufacturing facility and continued innovation.

  • Pureit acquisition doubled India water treatment scale, with minimal 2024 impact.

Financial highlights

  • 2024 sales were $3.8B, down 1% year-over-year; adjusted EPS was $3.73, down 2% from 2023; net earnings fell 4% to $533.6M.

  • Q4 sales were $912M, down 8% year-over-year; Q4 adjusted EPS was $0.85, down 12% from Q4 2023.

  • Free cash flow for 2024 was $474M, with a conversion rate of 89%, down from $598M in 2023.

  • Cash and marketable securities at year-end totaled $276M; net cash position $83M; debt was $193.2M.

  • Gross margin for 2024 was 38.1%, slightly down from 38.5% in 2023.

Outlook and guidance

  • 2025 net sales expected between $3.8B and $3.9B, flat to up 2%; adjusted EPS guidance $3.60–$3.90, with the midpoint slightly above 2024 actuals.

  • North America and Rest of World segment margins projected at 24–24.5% and 8–9%, respectively; free cash flow expected between $500M–$550M.

  • Capital expenditures planned at $90M–$100M; effective tax rate ~24–24.5%.

  • North America water treatment sales projected to decline ~5% in 2025 due to portfolio reprioritization, but with a 250 bps margin expansion; China sales expected to decrease 5–8% in local currency.

  • Board approved repurchase of $400M in shares, with 5M additional shares authorized for 2025.

Partial view of Summaries dataset, powered by Quartr API
AI can get things wrong. Verify important information.
All investor relations material. One API.
Learn more